United Therapeutics Corporation stock price

United Therapeutics Corporation latest news:


  • 02/15/2018 10:11:12

    BRIEF-Celularity Announces Formation Of Co With $250 Mln In Funding From Celgene, United Therapeutics, Others

    Celularity: * ‍CELULARITY ANNOUNCES $250 MILLION IN FUNDING TO DELIVER TREATMENTS FOR CANCER, INFLAMMATORY AND DEGENERATIVE DISEASES, AND FUNCTIONAL REGENERATION​. * CELULARITY SAYS IS ANNOUNCING FORMATION OF CO WITH $250 MILLION IN FUNDING WITH CONTRIBUTIONS FROM CELGENE, UNITED THERAPEUTICS (UTHR), SORRENTO THERAPEUTICS Source text for Eikon: Further company coverage:

  • 12/20/2017 10:08:33

    United Therapeutics to pay $210 million to settle government allegations of kickback payments

    United Therapeutics Corp. agreed Wednesday to pay $210 million to settle claims that it paid kickbacks to Medicare patients. The U.S. Attorney's office had alleged that the company violated the Anti-Kickback Statute of the False Claims Act, which prohibits drug companies from paying to induce Medicare patients to buy their drugs. The company, which sells a number of pulmonary arterial hypertension drugs, allegedly used a foundation claiming non-profit status as a conduit to pay the co-pay obligations of "thousands" of Medicare patients taking its drugs. "UT used a third party to do exactly what it knew it could not lawfully do itself," said Acting U.S. Attorney William Weinreb. The $210 million settlement is equal to 47% of total third-quarter revenue. United Therapeutics's stock gained 0.3% in midday trade. It has lost 5.2% year to date, while the S&P 500 has climbed 20%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/20/2017 09:53:19

    UPDATE 1-United Therapeutics to pay $210 mln to resolve U.S. kickback probe

    BOSTON, Dec 20 (Reuters) - United Therapeutics Corp will pay $210 million to resolve U.S. claims that the drugmaker used a charity as a conduit to illegally cover Medicare patients' out-of-pocket drug costs in order to eliminate price sensitivity and to boost sales.

  • 12/20/2017 09:17:10

    United Therapeutics to pay $210 mln to resolve U.S. kickback probe

    United Therapeutics Corp(UTHR) will pay $210 million to resolve U.S. claims that the drugmaker used a charity as a conduit to illegally cover Medicare patients' out-of-pocket drug costs in order to eliminate price sensitivity and to boost sales.

  • More trends:

    United-Guardian, Inc.UG | Unity Bancorp, Inc.UNTY | Universal Display CorporationOLED | Universal Electronics Inc.UEIC | Universal Forest Products, Inc.UFPI | Universal Stainless & Alloy Products, Inc.USAP | Universal Truckload Services, Inc.UACL | Univest Corporation of PennsylvaniaUVSP | Unwired Planet, Inc.UPIP | Upland Software, Inc.UPLD |